William S. Groene

992 total citations
14 papers, 800 citations indexed

About

William S. Groene is a scholar working on Genetics, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, William S. Groene has authored 14 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Infectious Diseases and 5 papers in Animal Science and Zoology. Recurrent topics in William S. Groene's work include Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (9 papers) and Animal Virus Infections Studies (5 papers). William S. Groene is often cited by papers focused on Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (9 papers) and Animal Virus Infections Studies (5 papers). William S. Groene collaborates with scholars based in United States and Canada. William S. Groene's co-authors include Robert M. Lorence, Michael K. Bamat, M. Scot Roberts, Robert D. Shaw, Daniel H. Sterman, Gary I. Cohen, Andrew L. Pecora, Harvey Rabin, John L. Marshall and Peter Groß and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Clinical Cancer Research.

In The Last Decade

William S. Groene

14 papers receiving 779 citations

Peers

William S. Groene

GENET

ID

ONCOL

ASZ

EPIDE

Petra B. van den Doel Netherlands

Brian C. Horsburgh United States

Arun Ammayappan United States

Alicia Gómez Yafal United States

Gene A. Palmer United States

Worth I. Capps United States

Donna C. Porter United States

Ralph Dornburg United States

Autumn Ruiz United States

Josephine S. Gnanandarajah United States

Petra B. van den Doel Netherlands

William S. Groene

233 ×0.4

GENET

345 ×1.3

ID

169 ×0.6

ONCOL

85 ×0.4

ASZ

119 ×0.5

EPIDE

Citations per year, relative to William S. Groene William S. Groene (= 1×) peers Petra B. van den Doel

Countries citing papers authored by William S. Groene

Since Specialization

Citations

This map shows the geographic impact of William S. Groene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Groene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Groene more than expected).

Fields of papers citing papers by William S. Groene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Groene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Groene. The network helps show where William S. Groene may publish in the future.

Co-authorship network of co-authors of William S. Groene

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Groene. A scholar is included among the top collaborators of William S. Groene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Groene. William S. Groene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Lorence, Robert M., M. Scot Roberts, James P. O’Neil, et al.. (2007). Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus. Current Cancer Drug Targets. 7(2). 157–167. 93 indexed citations

2.

Hotte, Sébastien J., Robert M. Lorence, Hal W. Hirte, et al.. (2007). An Optimized Clinical Regimen for the Oncolytic Virus PV701. Clinical Cancer Research. 13(3). 977–985. 98 indexed citations

3.

Laurie, Scott A., John C. Bell, Harold Atkins, et al.. (2006). A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization. Clinical Cancer Research. 12(8). 2555–2562. 103 indexed citations

4.

Lorence, Robert M., et al.. (2006). Naturally oncolytic viruses.. PubMed. 8(4). 314–21. 45 indexed citations

5.

Hotte, Sébastien J., Pierre Major, Holger W. Hirte, et al.. (2004). Slow intravenous infusion of PV701, an oncolytic virus: Final results of a phase I study. Journal of Clinical Oncology. 22(14_suppl). 3037–3037. 4 indexed citations

6.

Hotte, Sébastien J., Pierre Major, Holger W. Hirte, et al.. (2004). Slow intravenous infusion of PV701, an oncolytic virus: Final results of a phase I study. Journal of Clinical Oncology. 22(14_suppl). 3037–3037. 1 indexed citations

7.

Pecora, Andrew L., Naiyer A. Rizvi, Gary I. Cohen, et al.. (2002). Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers. Journal of Clinical Oncology. 20(9). 2251–2266. 314 indexed citations

8.

Lorence, Robert M., Andrew L. Pecora, Gary I. Cohen, et al.. (2001). An intravenous phase I trial of PV701, a replication-competent virus, in the treatment of patients with advanced solid cancers. European Journal of Cancer. 37. S65–S65. 5 indexed citations

9.

Roberts, M. Scot, et al.. (2001). Preclinical studies with PV701, a replication-competent oncolytic strain of newcastle disease virus. European Journal of Cancer. 37. S65–S65. 3 indexed citations

10.

Shaw, Robert D., et al.. (1993). Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year. Journal of Clinical Microbiology. 31(2). 188–191. 23 indexed citations

11.

Shaw, Robert D., et al.. (1992). Recombinant Baculovirus-Expressed Rotavirus Protein (VP4) in an ELISPOT Assay of Antibody Secretion. Viral Immunology. 5(1). 51–59. 4 indexed citations

12.

Groene, William S. & Robert D. Shaw. (1992). Psoralen preparation of antigenically intact noninfectious rotavirus particles. Journal of Virological Methods. 38(1). 93–102. 65 indexed citations

13.

Shaw, Robert D., et al.. (1991). VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection. Journal of Virology. 65(6). 3052–3059. 15 indexed citations

14.

Groene, William S., et al.. (1991). Murine intestinal antibody response to heterologous rotavirus infection. Journal of Clinical Microbiology. 29(8). 1693–1701. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact